Why is Laurus Labs falling/rising?

As of 17-Jul, Laurus Labs Ltd is currently priced at 821.55, reflecting a slight decline of 0.05 (-0.01%). The stock has been underperforming recently, having fallen for the last two days with a total decrease of 0.67%. Despite this, Laurus Labs has shown strong performance over the past month with a return of 25.05% and a remarkable 76.43% increase over the past year, significantly outpacing the broader market's 1.91% gain. The stock is also close to its 52-week high, just 1.57% away from 834.45. However, a notable drop in investor participation, with delivery volume decreasing by 62.66% compared to the 5-day average, may indicate waning interest among traders.
In the broader market context, Laurus Labs has outperformed the Sensex, which has declined by 1.12% over the past week while Laurus Labs gained 3.62%. The stock's high management efficiency, reflected in a return on capital employed (ROCE) of 18.50%, and strong financial results, including a 210.5% growth in net profit, support its positive outlook. However, the stock's expensive valuation, indicated by a high enterprise value to capital employed ratio, and a PEG ratio of 1 suggest potential risks. While institutional holdings are robust at 37.29%, indicating confidence from larger investors, the recent decline in trading volume and consecutive price drops may be causing concern among retail investors.